Return On Equity of Terns Pharmaceuticals, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Terns Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Terns Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -30%, a 8.6% increase year-over-year.
  • Terns Pharmaceuticals, Inc. annual Return On Equity for 2024 was -30%, a 9.1% increase from 2023.
  • Terns Pharmaceuticals, Inc. annual Return On Equity for 2023 was -34%, a 3.8% decline from 2022.
  • Terns Pharmaceuticals, Inc. annual Return On Equity for 2022 was -32%, a 13% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Terns Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -30% +3% +8.6% 01 Jul 2025 30 Sep 2025
Q2 2025 -27% +12% +31% 01 Apr 2025 30 Jun 2025
Q1 2025 -29% +7% +19% 01 Jan 2025 31 Mar 2025
Q4 2024 -30% +3% +9.1% 01 Oct 2024 31 Dec 2024
Q3 2024 -33% -2% -5.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -40% -11% -40% 01 Apr 2024 30 Jun 2024
Q1 2024 -36% -5% -16% 01 Jan 2024 31 Mar 2024
Q4 2023 -34% -1% -3.8% 01 Oct 2023 31 Dec 2023
Q3 2023 -31% +6% +17% 01 Jul 2023 30 Sep 2023
Q2 2023 -28% +7% +19% 01 Apr 2023 30 Jun 2023
Q1 2023 -31% 0% -0.69% 01 Jan 2023 31 Mar 2023
Q4 2022 -32% -4% -13% 01 Oct 2022 31 Dec 2022
Q3 2022 -37% +6% +13% 01 Jul 2022 30 Sep 2022
Q2 2022 -35% +101% +74% 01 Apr 2022 30 Jun 2022
Q1 2022 -31% -144% -127% 01 Jan 2022 31 Mar 2022
Q4 2021 -29% -64% -179% 01 Oct 2021 31 Dec 2021
Q3 2021 -43% 01 Jul 2021 30 Sep 2021
Q2 2021 -136% 01 Apr 2021 30 Jun 2021
Q1 2021 113% 01 Jan 2021 31 Mar 2021
Q4 2020 36% 01 Oct 2020 31 Dec 2020

Terns Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30% +3% +9.1% 01 Jan 2024 31 Dec 2024
2023 -34% -1% -3.8% 01 Jan 2023 31 Dec 2023
2022 -32% -4% -13% 01 Jan 2022 31 Dec 2022
2021 -29% -64% -179% 01 Jan 2021 31 Dec 2021
2020 36% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.